Pixel by LabCorp ℠ Offers Self-Collected Testing Anytime, Anywhere to Empower Healthcare Consumers BURLINGTON, N.C.--(BUSINESS WIRE)--LabCorp® (NYSE: LH), a leading global life sciences company, today ...

Clinical Development Business to be a Leading, Pure-Play Contract Research Organization with a Comprehensive Set of Clinical Trial Management, Market Access and Technology Capabilities Labcorp Remains ...

BURLINGTON, N.C.--(BUSINESS WIRE)--Labcorp (NYSE: LH), a leading global life sciences company, today announced that the new company to be formed by the planned spin-off of its Clinical Development ...

“Adding Toxikon underscores our commitment to nonclinical development and advances our capabilities for both drug development and medical device testing,” said Dr. Paul Kirchgraber, CEO of Labcorp ...

BURLINGTON, N.C., and EGG HARBOR TOWNSHIP, N.J.--(BUSINESS WIRE)--Labcorp (NYSE: LH), a leading global life sciences company, and AtlantiCare, the largest health care organization in southern New ...

Test Expands Labcorp’s Leadership In Bringing Testing Solutions for New Precision Medicines Used to Treat Patients With Lung Cancer Photo courtesy of Labcorp. Labcorp’s oncology platform brings ...

LabCorp Enters Definitive Agreement to Acquire Monogram Biosciences, Inc. Laboratory Corporation of America ® Holdings (LabCorp ® ) (NYSE: LH) and Monogram Biosciences, Inc. (NASDAQ: MGRM) today ...

Labcorp Holdings Inc. (NYSE: LH), a global leader of innovative and comprehensive laboratory services, will release its financial results for the first quarter of 2026 before the market opens on ...

Laboratory testing plays a critical role in healthcare, informing nearly 70% of clinical decisions and often serving as the first step in diagnosing and managing patient conditions. Yet research shows ...

The biomarker test measures NfL levels through standard blood collection. Labcorp has launched the Neurofilament Light Chain (NfL) blood test to identify and verify signs of neuronal damage related to ...

Labcorp Holdings Inc. (NYSE: LH), a global leader of innovative and comprehensive laboratory services, announced today that its Board of Directors has declared a cash dividend of $0.72 per share of ...

Clients: Physicians, patients, biopharmaceutical companies, government agencies, managed care organizations, hospitals and clinical labs. Specialty testing group: Includes endocrine testing; ...